S_inary The prognostic value of oestrogen receptor (ER) and progesterone receptor (PR) was estimated through a multicentric study of 2257 operable breast cancer patients followed up for a median of 8.5 years. None of the patients had received adjuvant therapy. 
Several lines of data suggest that the expression of oestrogen and progesterone receptors in the primary tumour is related to the degree of differentiation of the tumour and its proliferation rate. The prognostic value of steroid receptors is probably linked to this relationship.
Nevertheless, many discrepant results have been published relating to the actual prognostic value of steroid receptors. Several reports show that, with increasing follow-up, the initial advantage of positive receptor assays in terms of disease-free interval and survival vanishes (review in Raemaekers et al., 1985) .
To address this question we set up a multicentric study of patients diagnosed and treated for primary breast cancer from the beginning of the 1970s. None of the patients had received adjuvant therapy, and receptor assays were all performed using radioligand techniques according to French national protocol (Martin et al., 1981) .
Patient and methosi Patients
The 2257 patients were diagnosed and treated between the beginning of 1974 and the end of 1984 at eight different cancer centres, and the results of their follow-up were studied up to September 1993. The median follow-up time was 8.5 years. At 5 years 7.7% of the patients were lost to follow-up. Bilateral cancers and patients with any kind of adjuvant therapy were excluded from the study.
Information was recorded for each patient including age and hormonal status at diagnosis, clinical stage, histological classification and grade, pathological size and axillary lymph nodes status, steroid receptor status, as well as primary treatment (Table I) .
The mean age of the patients was 59 years (range 20-98 years) and 74 patients (3.3%) were under 35 years. Sixty-five per cent of the patients were post-menopausal (range between centres 14-44%). Significant differences (P<0.0001) in the mean ages (range 55-65 years) and in the proportion of menopausal patients (range 14-44%) were also observed between centres.
Staging of the disease was performed according to the UICC criteria (stage I, 33.3%; stage II, 57.1%; stage IIIa, 5.7% and 2.4% stage IIb) ( Table I ). Significant differences (P<0.0001) in the proportions of the different stages were also observed between centres (range 13-55% for stage I and 44-68% for stage II). The primary treatment was tumorectomy (32.7%) or mastectomy with axillary dissection (67.3%), followed by radiotherapy for 49.4% of cases.
Complete follow-up histories of the patients were recorded. During the first year, the follow-up was conducted at 3 month intervals, then over the following 2 year period at 6 month intervals, and thereafter annually.
Methods
Histology Tumour size was recorded as the maximum diameter of the surgically removed tumour mass. Axillary lymph nodes status (mean number examined: 13) was assessed by histological examination for 2045 patients. Grading of the tumours was performed according to the Scarff, Bloom and Richardson method (SBR) (Bloom and Richardson, 1957 (Kaplan and Meier, 1958) . Survival rates are presented with their standard deviation (±s.d.). The prognostic value of ER or PR was tested using the log-rank test (Peto and Peto, 1972) , with an estimation of their unadjusted risk ratio. The influence of ER and PR on prognosis, adjusted for the other prognostic factors, was assessed in a multivariate analysis by the Cox proportional hazard regression model in a forward stepwise procedure (Cox, 1972 ([b' + b" f(t)]Z) with two functions of time: fit) =time and fit) = Ln (time). Annual relative risks, calculated by using the timedependent hazard function are presented on the same figure as the model curves. All statistical analyses were performed by using BMDP programs.
Resuhs Histopathology and receptors
The mean size of the tumours was 28.9 mm (range between centres 20.4-35.6 mm). A total of 1511 (66.9%) patients were node negative, 443 (19.6%) had 1-3 invaded nodes, 91 (4.0%) more than four invaded nodes (range between centres for node-negative patients 42-100%). Eighty-two per cent were ductal carcinomas, 4.6% were lobular carcinomas, the other particular histological types were recorded as a whole group (13.4%). In all 20.6% were SBR grade I (range between centres 14-53%), 50.7% were SBR grade II (range 21-70%), 17.8% were SBR grade III (range 9-36%) ( Table  I ). Significant variations in the mean tumour size, proportions of positive or negative lymph nodes and in the three SBR groups were observed between different centres (P<0.001).
Some 68.8% of the tumours were ER positive (mean concentration 93 fmol mg-' cytosol protein), 54.0% were PR positive (mean concentration 73 fmol mg-' protein). For 223 cases only one receptor could be measured because of insufficient tumour tissue. Positivity for both receptors was observed in 53.3% of the tumours, 23.9% were all negative, 19.8% were only ER positive and 3.0% only PR positive. Figure 6 ). (Adami et al., 1986; Host and Lund, 1986) , showing that the differences in overall survival are at a maximum when using that cut-off. The influence of these factors on disease-free interval, occurrence of metastases and survival was evaluated in a forward stepwise regression. The results for the three models are presented in Table V (Aaltomaa et al., 1991) to ten (Chevallier et al., 1988) , may explain the diverse conclusions obtained. But, when both ER and PR were tested in the Cox model, a majority (7j9) of the studies concluded a better significance or a unique significance of PR and 3/11 showed a prognostic value for ER alone or for both receptors. It can be observed that the prognostic value of PR was particularly evidenced when the patients received adjuvant treatment.
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The ER vanishing prognostic value, reaching a nonsignificant relative risk between negative and positive tumours during the follow-up, is difficult to analyse. A similar trend was previously described by Spyratos et al. (1989) 
